Revasum, Inc. reported earnings results for the full year ended January 02, 2023. For the full year, the company reported sales was USD 14.75 million compared to USD 13.71 million a year ago. Net loss was USD 8.93 million compared to USD 1.97 million a year ago.

Basic loss per share from continuing operations was USD 0.08 compared to USD 0.02 a year ago.